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1. Introduction 
The nature and localization of the mutations 
responsible for the electrophoretic variants of human 
serumalbumin (HSA) have not been established so 
far, except in the case of the slow albumin B which 
is the most frequent variant among Europeans. It is 
due to a substitution of glutamic acid by lysine near 
the C-terminal of HSA at position 569 [l] in the 
numbering system of Behrens et al. [2] . 
Albumin Gainesville is another slow-variant of
HSA which is very rare and has been described by 
Lau et al. [3] , in a family of Irish descent. One 
identical case has been found in France and reported 
in [4]. Normal and slow albumins have been isolated 
from the serum of an heterozygote member of the 
French family. Both albumins have been degraded by 
cyanogen bromide. Study of the electrophoretic 
mobility of the fragments so obtained shows that the 
mutation responsible for the slow albumin is located 
in the N-terminal quarter of the albumin molecule. 
2. Materials and methods 
Serum was collected from a 73 year-old woman (Y) 
having a bisalbuminaemia. Identity between this case 
and the albumin Gainesville has been established by 
Weitkamp et al. [4]. 
Slow variant and normal albumins from the serum 
of Y were separated as described by Winter et al. [5] 
with some modifications. Four ml serum were dialyzed 
Abbreviation: HSA, human serumalbumin 
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during 48 h against sodium phosphate buffer 0.15 M, 
pH 5.75 and chromatographied on a (1 X 90 cm) 
column of DEAE-Sephadex. Elution was carried out 
with the same buffer. The appropriate peaks were 
pooled, dialyzed against distilled water and lyophilized. 
Serum Y, isolated slow variant and normal albumins 
were assayed by electrophoresis on cellulose acetate 
with Sebia apparatus inveronal sodium buffer 0.04 M, 
pH 9.2. Two fl serum diluted l/4 in buffer and 2 ,ul 
albumin solution (20 mg/ml buffer) were used. The 
strips were stained with Ponceau S. 
Slow variant and normal albumins from serum Y 
were degraded by cyanogen bromide and the fragments 
were separated by filtration on Sephadex G-100 as 
described by Meloun and Kusnir [6]. Fragment 
nomenclature is that of McMenamy et al. [7]. 
Fragment A was further purified and chromatographied 
on CM-cellulose CM-32 as described by Lapresle and 
Doyen [8] . 
Fragment A and mixture of fragments B and C 
were assayed by electrophoresis in polyacrylamide- 
agarose gel as described by Uriel [9] with plates from 
Industrie Biologique Francaise (Indubiose plates) in 
Tris-glycine buffer, pH 8.7. Ten ~1 solution of frag- 
ment A (20 mg/ml buffer) and 10 ~1 mixture of 
fragments B and C (40 mg/ml buffer) were used. The 
peptides were stained with Coomassie Blue. 
3. Results and discussion 
The DEAE-Sephadex chromatography of serum Y 
is shown in fig. 1. Pooled and lyophilized slow variant 
and normal albumins were tested for purity by 
North-Hollalzd Atblishing Company - Amsterdam 
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Fig.1. Chromatographic separation on DEAE-Sephadex of the slow-variant and normal albumins from the serum Y. Horizontal 
bars indicate regions that were pooled. 
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Fig.2. Cellulose acetate electrophoresis of serum Y and of 
the slow (S) and normal (N) albumins isolated from this 
serum. 14 V/cm, duration 75 min. 
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Fig.3. Electrophoresis in polyacrylamide-agarose gel of 
fragments A,B,C of normal (N) and slow (S) albumins 
isolated from serum Y. 10 V/cm, duration 3 h. 
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electrophoresis in cellulose acetate. Figure 2 shows 
that there is a very slight contamination of the normal 
albumin by the slow variant. 
Degradation of human serum albumin by cyanogen 
bromide gives rise to three fragments which have been 
named by McMenamy et al. [7] B, C and A, from the 
N- to the C-terminal end of albumin molecule. Frag- 
ment A, which corresponds approximately to one half 
of the albumin molecule, is separated by gel-filtration 
on Sephadex G-l 00 from fragments B and C corre- 
sponding to approximately one quarter of the albumin 
molecule, and elute together. 
Degradation by cyanogen bromide of slow-variant 
and normal albumins from serum Y gives rise in both 
cases to the three fragments A, B and C. Figure 3 shows 
the electrophoretic pattern in polyacrylamide-agarose 
gel of fragment A and the mixture of fragments B and 
C. Fragments A and C from the slow and normal 
albumins have the same mobilities whereas fragment B 
from the slow albumin has a slower mobility than 
fragment B from normal albumin. This demonstrates 
that the mutation responsible for the Gainesville albu- 
min variant is located in the part of the albumin 
molecule corresponding to fragment B with the excep- 
tion of the C-terminal methionine, i.e., in the first 
122 residues of albumin, according to the sequence of 
Behrens et al. [2] or Meloun et al. [lo] . 
Electrophoretic study of cyanogen bromide frag- 
ments of isolated variant and normal albumins from 
bisalbuminaemia can thus provide a first indication 
concerning the localization of the mutation. 
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